245 related articles for article (PubMed ID: 35203791)
21. Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant
Karruli A; Migliaccio A; Pournaras S; Durante-Mangoni E; Zarrilli R
Antibiotics (Basel); 2023 Dec; 12(12):. PubMed ID: 38136764
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
[TBL] [Abstract][Full Text] [Related]
23. Induced Heteroresistance in Carbapenem-Resistant
Mezcord V; Escalante J; Nishimura B; Traglia GM; Sharma R; Vallé Q; Tuttobene MR; Subils T; Marin I; Pasteran F; Actis LA; Tolmasky ME; Bonomo RA; Rao G; Ramirez MS
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511511
[TBL] [Abstract][Full Text] [Related]
24. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against
Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F
Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593
[TBL] [Abstract][Full Text] [Related]
25. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
[TBL] [Abstract][Full Text] [Related]
26.
Takemura M; Nakamura R; Ota M; Nakai R; Sahm DF; Hackel MA; Yamano Y
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0034623. PubMed ID: 37971240
[No Abstract] [Full Text] [Related]
27.
Naas T; Lina G; Santerre Henriksen A; Longshaw C; Jehl F
JAC Antimicrob Resist; 2021 Jun; 3(2):dlab081. PubMed ID: 34223140
[TBL] [Abstract][Full Text] [Related]
28. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
29.
Takemoto K; Nakayama R; Fujimoto K; Suzuki Y; Takarabe Y; Honsho M; Kitahara S; Noguchi Y; Matsui H; Hirose T; Asami Y; Hidaka J; Sunazuka T; Hanaki H
Antimicrob Agents Chemother; 2024 May; ():e0160223. PubMed ID: 38709005
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015.
Karlowsky JA; Hackel MA; Tsuji M; Yamano Y; Echols R; Sahm DF
Int J Antimicrob Agents; 2019 Apr; 53(4):456-466. PubMed ID: 30471402
[TBL] [Abstract][Full Text] [Related]
31. Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against
Lasarte-Monterrubio C; Vázquez-Ucha JC; Maneiro M; Arca-Suárez J; Alonso I; Guijarro-Sánchez P; Buynak JD; Bou G; González-Bello C; Beceiro A
Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33672671
[TBL] [Abstract][Full Text] [Related]
32. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
33. Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria.
Palombo M; Bovo F; Amadesi S; Gaibani P
Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237761
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
35. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
36. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
[TBL] [Abstract][Full Text] [Related]
37. [Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
Sarı B; Baran I; Alaçam S; Mumcuoğlu İ; Kurşun Ş; Aksu N
Mikrobiyol Bul; 2015 Apr; 49(2):249-58. PubMed ID: 26167825
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
Seifert H; Müller C; Stefanik D; Higgins PG; Miller A; Kresken M
J Antimicrob Chemother; 2020 Sep; 75(9):2616-2621. PubMed ID: 32516359
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
40. Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-20017) in relation to phylogenetic background, sequence type 131 subclones, bla
Johnston BD; Thuras P; Porter SB; Clabots C; Johnsona JR
Diagn Microbiol Infect Dis; 2021 May; 100(1):115314. PubMed ID: 33578059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
